Selected research
Market Structure
Global Galactomannan ELISA Kits Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Galactomannan ELISA Kits market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Galactomannan ELISA Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Galactomannan ELISA Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Galactomannan ELISA Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Galactomannan ELISA Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Galactomannan ELISA Kits include GaDia, Krishgen Biosystems, Biorbyt, Emelca Bio, Genobio, Eurobio-Scientific, Bio‑State, ELK Biotechnology and Tianjin Tailian Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Galactomannan ELISA Kits market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Galactomannan ELISA Kits and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Galactomannan ELISA Kits sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Galactomannan ELISA Kits market size, projected growth trends, production technologies, key applications, and end-use industries.
Galactomannan ELISA Kits Segment by Company
GaDia
Krishgen Biosystems
Biorbyt
Emelca Bio
Genobio
Eurobio-Scientific
Bio‑State
ELK Biotechnology
Tianjin Tailian Biotech
AFG Scientific
Bioassay Technology Laboratory
MyBioSource
SICBIO (Shenzhen)
Shanghai Zhenzhun Biotechnology
Grzan
Galactomannan ELISA Kits Segment by Type
Sandwich ELISA Kit
Competitive ELISA Kit
Galactomannan ELISA Kits Segment by Application
Clinical Diagnosis
Scientific Research
Galactomannan ELISA Kits Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Galactomannan ELISA Kits market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Galactomannan ELISA Kits and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Galactomannan ELISA Kits.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Galactomannan ELISA Kits market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Galactomannan ELISA Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Galactomannan ELISA Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Galactomannan ELISA Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Sandwich ELISA Kit
- Competitive ELISA Kit
Applications
- Clinical Diagnosis
- Scientific Research
Companies covered
- GaDia
- Krishgen Biosystems
- Biorbyt
- Emelca Bio
- Genobio
- Eurobio-Scientific
- Bio‑State
- ELK Biotechnology
- Tianjin Tailian Biotech
- AFG Scientific
- Bioassay Technology Laboratory
- MyBioSource
- SICBIO (Shenzhen)
- Shanghai Zhenzhun Biotechnology
- Grzan
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Galactomannan ELISA Kits Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Galactomannan ELISA Kits Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Galactomannan ELISA Kits Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Galactomannan ELISA Kits Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Galactomannan ELISA Kits Market Dynamics
- 2.1 Galactomannan ELISA Kits Industry Trends
- 2.2 Galactomannan ELISA Kits Industry Drivers
- 2.3 Galactomannan ELISA Kits Industry Opportunities and Challenges
- 2.4 Galactomannan ELISA Kits Industry Restraints
3 Galactomannan ELISA Kits Market by Manufacturers
- 3.1 Global Galactomannan ELISA Kits Revenue by Manufacturers (2021-2026)
- 3.2 Global Galactomannan ELISA Kits Sales by Manufacturers (2021-2026)
- 3.3 Global Galactomannan ELISA Kits Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Galactomannan ELISA Kits Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Galactomannan ELISA Kits Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Galactomannan ELISA Kits Manufacturers, Product Type & Application
- 3.7 Global Galactomannan ELISA Kits Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Galactomannan ELISA Kits Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Galactomannan ELISA Kits Players Market Share by Revenue in 2025
- 3.8.3 2025 Galactomannan ELISA Kits Tier 1, Tier 2, and Tier 3
4 Galactomannan ELISA Kits Market by Type
- 4.1 Galactomannan ELISA Kits Type Introduction
- 4.1.1 Sandwich ELISA Kit
- 4.1.2 Competitive ELISA Kit
- 4.2 Global Galactomannan ELISA Kits Sales by Type
- 4.2.1 Global Galactomannan ELISA Kits Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Galactomannan ELISA Kits Sales by Type (2021-2032)
- 4.2.3 Global Galactomannan ELISA Kits Sales Market Share by Type (2021-2032)
- 4.3 Global Galactomannan ELISA Kits Revenue by Type
- 4.3.1 Global Galactomannan ELISA Kits Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Galactomannan ELISA Kits Revenue by Type (2021-2032)
- 4.3.3 Global Galactomannan ELISA Kits Revenue Market Share by Type (2021-2032)
5 Galactomannan ELISA Kits Market by Application
- 5.1 Galactomannan ELISA Kits Application Introduction
- 5.1.1 Clinical Diagnosis
- 5.1.2 Scientific Research
- 5.2 Global Galactomannan ELISA Kits Sales by Application
- 5.2.1 Global Galactomannan ELISA Kits Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Galactomannan ELISA Kits Sales by Application (2021-2032)
- 5.2.3 Global Galactomannan ELISA Kits Sales Market Share by Application (2021-2032)
- 5.3 Global Galactomannan ELISA Kits Revenue by Application
- 5.3.1 Global Galactomannan ELISA Kits Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Galactomannan ELISA Kits Revenue by Application (2021-2032)
- 5.3.3 Global Galactomannan ELISA Kits Revenue Market Share by Application (2021-2032)
6 Global Galactomannan ELISA Kits Sales by Region
- 6.1 Global Galactomannan ELISA Kits Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Galactomannan ELISA Kits Sales by Region (2021-2032)
- 6.2.1 Global Galactomannan ELISA Kits Sales by Region (2021-2026)
- 6.2.2 Global Galactomannan ELISA Kits Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Galactomannan ELISA Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Galactomannan ELISA Kits Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Galactomannan ELISA Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Galactomannan ELISA Kits Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Galactomannan ELISA Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Galactomannan ELISA Kits Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Galactomannan ELISA Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Galactomannan ELISA Kits Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Galactomannan ELISA Kits Revenue by Region
- 7.1 Global Galactomannan ELISA Kits Revenue by Region
- 7.1.1 Global Galactomannan ELISA Kits Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Galactomannan ELISA Kits Revenue by Region (2021-2026)
- 7.1.3 Global Galactomannan ELISA Kits Revenue by Region (2027-2032)
- 7.1.4 Global Galactomannan ELISA Kits Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Galactomannan ELISA Kits Revenue (2021-2032)
- 7.2.2 North America Galactomannan ELISA Kits Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Galactomannan ELISA Kits Revenue (2021-2032)
- 7.3.2 Europe Galactomannan ELISA Kits Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Galactomannan ELISA Kits Revenue (2021-2032)
- 7.4.2 Asia-Pacific Galactomannan ELISA Kits Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Galactomannan ELISA Kits Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Galactomannan ELISA Kits Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 GaDia
- 8.1.1 GaDia Company Information
- 8.1.2 GaDia Business Overview
- 8.1.3 GaDia Galactomannan ELISA Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 GaDia Galactomannan ELISA Kits Product Portfolio
- 8.1.5 GaDia Recent Developments
- 8.2 Krishgen Biosystems
- 8.2.1 Krishgen Biosystems Company Information
- 8.2.2 Krishgen Biosystems Business Overview
- 8.2.3 Krishgen Biosystems Galactomannan ELISA Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Krishgen Biosystems Galactomannan ELISA Kits Product Portfolio
- 8.2.5 Krishgen Biosystems Recent Developments
- 8.3 Biorbyt
- 8.3.1 Biorbyt Company Information
- 8.3.2 Biorbyt Business Overview
- 8.3.3 Biorbyt Galactomannan ELISA Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Biorbyt Galactomannan ELISA Kits Product Portfolio
- 8.3.5 Biorbyt Recent Developments
- 8.4 Emelca Bio
- 8.4.1 Emelca Bio Company Information
- 8.4.2 Emelca Bio Business Overview
- 8.4.3 Emelca Bio Galactomannan ELISA Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Emelca Bio Galactomannan ELISA Kits Product Portfolio
- 8.4.5 Emelca Bio Recent Developments
- 8.5 Genobio
- 8.5.1 Genobio Company Information
- 8.5.2 Genobio Business Overview
- 8.5.3 Genobio Galactomannan ELISA Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Genobio Galactomannan ELISA Kits Product Portfolio
- 8.5.5 Genobio Recent Developments
- 8.6 Eurobio-Scientific
- 8.6.1 Eurobio-Scientific Company Information
- 8.6.2 Eurobio-Scientific Business Overview
- 8.6.3 Eurobio-Scientific Galactomannan ELISA Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Eurobio-Scientific Galactomannan ELISA Kits Product Portfolio
- 8.6.5 Eurobio-Scientific Recent Developments
- 8.7 Bio‑State
- 8.7.1 Bio‑State Company Information
- 8.7.2 Bio‑State Business Overview
- 8.7.3 Bio‑State Galactomannan ELISA Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Bio‑State Galactomannan ELISA Kits Product Portfolio
- 8.7.5 Bio‑State Recent Developments
- 8.8 ELK Biotechnology
- 8.8.1 ELK Biotechnology Company Information
- 8.8.2 ELK Biotechnology Business Overview
- 8.8.3 ELK Biotechnology Galactomannan ELISA Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 ELK Biotechnology Galactomannan ELISA Kits Product Portfolio
- 8.8.5 ELK Biotechnology Recent Developments
- 8.9 Tianjin Tailian Biotech
- 8.9.1 Tianjin Tailian Biotech Company Information
- 8.9.2 Tianjin Tailian Biotech Business Overview
- 8.9.3 Tianjin Tailian Biotech Galactomannan ELISA Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Tianjin Tailian Biotech Galactomannan ELISA Kits Product Portfolio
- 8.9.5 Tianjin Tailian Biotech Recent Developments
- 8.10 AFG Scientific
- 8.10.1 AFG Scientific Company Information
- 8.10.2 AFG Scientific Business Overview
- 8.10.3 AFG Scientific Galactomannan ELISA Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 AFG Scientific Galactomannan ELISA Kits Product Portfolio
- 8.10.5 AFG Scientific Recent Developments
- 8.11 Bioassay Technology Laboratory
- 8.11.1 Bioassay Technology Laboratory Company Information
- 8.11.2 Bioassay Technology Laboratory Business Overview
- 8.11.3 Bioassay Technology Laboratory Galactomannan ELISA Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Bioassay Technology Laboratory Galactomannan ELISA Kits Product Portfolio
- 8.11.5 Bioassay Technology Laboratory Recent Developments
- 8.12 MyBioSource
- 8.12.1 MyBioSource Company Information
- 8.12.2 MyBioSource Business Overview
- 8.12.3 MyBioSource Galactomannan ELISA Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 MyBioSource Galactomannan ELISA Kits Product Portfolio
- 8.12.5 MyBioSource Recent Developments
- 8.13 SICBIO (Shenzhen)
- 8.13.1 SICBIO (Shenzhen) Company Information
- 8.13.2 SICBIO (Shenzhen) Business Overview
- 8.13.3 SICBIO (Shenzhen) Galactomannan ELISA Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 SICBIO (Shenzhen) Galactomannan ELISA Kits Product Portfolio
- 8.13.5 SICBIO (Shenzhen) Recent Developments
- 8.14 Shanghai Zhenzhun Biotechnology
- 8.14.1 Shanghai Zhenzhun Biotechnology Company Information
- 8.14.2 Shanghai Zhenzhun Biotechnology Business Overview
- 8.14.3 Shanghai Zhenzhun Biotechnology Galactomannan ELISA Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Shanghai Zhenzhun Biotechnology Galactomannan ELISA Kits Product Portfolio
- 8.14.5 Shanghai Zhenzhun Biotechnology Recent Developments
- 8.15 Grzan
- 8.15.1 Grzan Company Information
- 8.15.2 Grzan Business Overview
- 8.15.3 Grzan Galactomannan ELISA Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Grzan Galactomannan ELISA Kits Product Portfolio
- 8.15.5 Grzan Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Galactomannan ELISA Kits Value Chain Analysis
- 9.1.1 Galactomannan ELISA Kits Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Galactomannan ELISA Kits Production Mode & Process
- 9.2 Galactomannan ELISA Kits Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Galactomannan ELISA Kits Distributors
- 9.2.3 Galactomannan ELISA Kits Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst